Date | Title | Description |
14.03.2024 | Amolyt Pharma, an Andera Partners’ portfolio company, announ... | Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therape... |
14.03.2024 | Andera Partners’ portfolio company Tubulis closes upsized €1... | Andera Partners’ portfolio company Tubulis today announced the successful completion of an upsized a... |
28.02.2024 | Andera Partners raises a final amount of € 233 million for A... | The fundraising of Andera Smart Infra 1 highlights the strong interest of investors (including the E... |
21.02.2024 | MMI Raises $110 Million in Series C Financing | The funds will support commercialization of the Symani® Surgical System in high-growth markets and c... |
12.02.2024 | Internship Offer – Andera Life Sciences | Andera Life Sciences, part of Andera Partners, is one of the leading Life Sciences venture capital t... |
12.02.2024 | 2023 Report – After a record year of investments and exits, ... | Andera Partners, a leading private equity investment firm, had a particularly active 2023, with €627... |
24.01.2024 | Meogroup initiates a new development cycle with the support ... | Since its inception by Richard Caron in 2005, Meogroup has specialised in providing operational supp... |
23.01.2024 | Andera Partners welcomes Sophie ELKRIEF as Business Developm... | Sophie ELKRIEF has worked her entire career in the financial sector. She started in investment banki... |
18.01.2024 | Mistertemp’ group announces the reorganization of its shareh... | Established in 2009 and based in Paris, Mistertemp’ group provides a multichannel offer of HR servic... |
21.12.2023 | Spanish energy transition developer INGENOSTRUM accelerates,... | The expert in renewable energy project development |
14.12.2023 | The Efor Group joins forces with the Nodarius Group, which i... | Driven by its dynamism and market recognition, the group aims to extend its international scope, par... |
05.12.2023 | The Imagerie Cardinet Group strengthens its position to acce... | Established in 1980, Imagerie Cardinet is a medical imaging group operating in Ile-de-France. The gr... |
30.11.2023 | mylight150 secures €100m to accelerate the expansion of its ... | The leader in solar self-consumption solutions |
14.11.2023 | Andera Partners co-leads a €67.5 million ($72 million) overs... | Andera Partners, a leading European private equity player, today announces that it is co-leading a €... |
13.11.2023 | Andera Partners joins forces with Founders of Gosto Group in... | Established in 1998 in Wasquehal, the Gosto Group is a multichannel distributor of commercial, offic... |
27.10.2023 | JenaValve Announces Late-Breaking Data from the ALIGN-AR Piv... | The trial met prespecified non-inferiority criteria for its primary safety endpoint and primary effi... |
11.10.2023 | Agomab Raises $100 Million Series C to Advance Fibrosis-focu... | Agomab Therapeutics NV (‘Agomab’) today announced the closing of a $100 million (€94.9 million) Seri... |
10.10.2023 | ELAN Languages acquires Dutch company AVB Vertalingen | ElaN Languages, which has a turnover of around €30m following the June 2023 acquisition of Lingua-Wo... |
05.10.2023 | Andera Acto supports EFOR’s ambition of becoming a global le... | Since its inception, EFOR has demonstrated continuous growth exceeding 20% per year in a resilient m... |
05.10.2023 | Agomab Receives FDA Fast Track Designation for AGMB-129 in F... | Agomab Therapeutics NV (‘Agomab’) announces that it received Fast Track Designation from the U.S. Fo... |
04.10.2023 | Andera Partners completes full exit from Travelsoft Group an... | - |
18.09.2023 | Andera Partners increases the hard cap for Andera MidCap 5 a... | This fundraising success highlights the strong interest investors have in the deep and resilient Eur... |
24.07.2023 | Crescendo Biologics secures $32M and announces expansion of ... | Crescendo Biologics Ltd (Crescendo), a clinical stage immuno-oncology company developing novel, targ... |
11.07.2023 | 2022 Sustainability Report | For the first year, Andera Partners has published a Sustainability strategy covering responsible inv... |
06.07.2023 | PAI Partners to acquire majority stake in Infra Group | PAI Partners (“PAI”), a pre-eminent private equity firm, today announces its agreement to acquire a ... |
04.07.2023 | ELAN Languages completes acquisition of German group Lingua-... | ElaN Languages, which has a turnover of around €20m, has built up a solid reputation over the past 3... |
29.06.2023 | Andera Acto supports Auris Group in restructuring of its cap... | Paris, 29 June 2023 – |
27.06.2023 | Allecra Therapeutics Submits New Drug Application to the U.S... | Allecra Therapeutics (“Allecra”) announced today the submission of a New Drug Application (NDA) to t... |
19.06.2023 | Siparex ETI finalises agreement to become majority sharehold... | Passman, leader in networks management and digital solutions for hospitality establishments, will op... |
14.06.2023 | Andera Partners and Pauwels Consulting management team join ... | Founded in 1999 by its CEO Bert Pauwels, Pauwels Consulting has achieved a leading market position a... |
01.06.2023 | Inotrem announces publication of two key articles on nangibo... | Inotrem, an advanced clinical stage biotech company specializing in immunotherapies for acute and ch... |
15.05.2023 | Andera Partners co-leads a €40 million Series A of Dualyx, a... | Andera Partners co-leads a €40 million Series A financing of Dualyx NV, a Ghent, Belgium based biote... |
10.05.2023 | Andera Partners appoints Stefan Keitel Senior Advisor DACH r... | Accelerating its ambitions in the German, Austrian and Swiss (DACH) region, Andera Partners is pleas... |
25.04.2023 | OneXillium group partners with Andera Acto to support them i... | Established in 1989 and based in the Netherlands in Woerden, OneXillium has since the outset acted a... |
20.04.2023 | Tubulis Announces Strategic License Agreement with Bristol M... | Tubulis and Bristol Myers Squibb (NYSE: BMY) today announced that they have entered into a strategic... |
18.04.2023 | Andera Partners co-leads a Series A extension round of € 47.... | Andera Partners, a leading European private equity player, today announces the successful completion... |
13.04.2023 | Andera Partners leads $48.5 Million Series A financing for m... | Andera Partners, a leading European private equity player, today announces that it is leading a $48.... |
05.04.2023 | BEA Group (Andera Acto) expands in Italy, through acquisitio... | PARIS, 5 april 2023 – BEA Group, supported by Andera Partners, announces the acquisition of the Capa... |
29.03.2023 | Grey Wolf Therapeutics Announces Dosing of First Patient in ... | Grey Wolf Therapeutics, a biotechnology company focused on generating entirely novel anti-tumour imm... |
22.03.2023 | Andera Acto supports SPS Group, a member of the ECF network,... | PARIS, 22 MARCH 2023 – Advised by Crédit Agricole Midcap Advisors, the shareholders of SPS are under... |
15.03.2023 | Andera Partners co-leads $25m extension round for FIRE1 | Andera Partners, a leading European private equity player, today announces a $25m extension round, c... |
15.03.2023 | NG Travel Group chooses Andera Acto to support them in their... | PARIS, 15 MARCH 2023 – Olivier Kervella, director of NG Travel, and his management team chose Andera... |
03.03.2023 | Flamingo Therapeutics and Dynacure Announce Merger to Create... | Therapeutics (“Flamingo”) and Dynacure, announced today that the companies have signed a definitive ... |
01.03.2023 | Redslim partners with Andera Acto to support them in their n... | - |
16.02.2023 | 2022 Report – Andera Partners | Andera Partners, a leading European private capital investment firm was particularly active in 2022 ... |
13.02.2023 | Andera Partners Portfolio Company Mineralys Therapeutics Suc... | Andera has co-led the company’s $118 million Series B financing in June 2022 and re-invested into th... |
02.02.2023 | Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-... | Agomab Therapeutics NV (‘Agomab’) today announced positive clinical results from its Phase 1 study e... |
26.01.2023 | Andera Partners Participates in the €45 Million Series B Fin... | Grey Wolf Therapeutics, a biotechnology company focused on generating entirely novel anti-tumour imm... |
23.01.2023 | Andera Partners reaches its €600 million target for Andera M... | This fundraising success highlights the strong interest investors have in Andera MidCap’s change of ... |
10.01.2023 | Andera Partners invests in SoniVie, a medtech company develo... | SoniVie Ltd. (“SoniVie” or the “Company”), a medical device company developing a proprietary solutio... |
09.01.2023 | Andera Partners participates in the $138 Million Series C Fi... | Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine an... |
14.12.2022 | Andera Partners opens its Milan office | (To read the press release in Italian, please click here) |
25.10.2022 | KLUBB Group acquires Isoli S.p.A. | Founded in 1946 and headquartered in Fontanaviva (near Padova), Isoli represents a reference player ... |
20.10.2022 | T-knife Therapeutics Announces Dosing of First Patient with ... | San Francisco, CA and Berlin, Germany – October 20, 2022 – T-knife Therapeutics, Inc., a clinical-st... |
13.10.2022 | Andera Partners invests in a high-performance detection solu... | Founded in 1986 by Rémi Kirchdoerffer and headquartered in Saverne, France, Senstronic is a leading ... |
10.10.2022 | New governance for Andera Partners | Andera Partners is renewing its two main governance bodies: |
10.10.2022 | Andera Partners raises its largest life sciences fund at €45... | The sixth generation of BioDiscovery funds is consolidating Andera Partners’ position as one of the ... |
04.10.2022 | Ozitem chooses Andera Acto to support them in their capital ... | PARIS, 4 OCTOBER 2022 – François Espieux, director of Ozitem, and his management team have chosen An... |
03.10.2022 | Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Thera... | LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a pioneering clinical-stage genomic medicine company, t... |
16.09.2022 | JenaValve Completes Enrollment in the ALIGN-ARIDE Clinical T... | The ALIGN-AR trial is a landmark prospective, single-arm investigation device exemption (IDE) study ... |
15.09.2022 | TRiCares Raises €47m in a First Closing of its Series C | The proceeds of this financing will primarily be used to continue the development of the company’s t... |
12.09.2022 | Agomab Therapeutics Selected as One of Fierce Biotech’s “Fie... | Agomab is a Belgian-headquartered biotech company developing a portfolio of unique small molecule co... |
30.08.2022 | French electric vehicle charging points market | 1. Commercial road transport sector |
30.08.2022 | Heat, the forsaken vector of a renewable future | In the quest for a carbon neutral future, renewable energies thrust the spotlight. At the French lev... |
30.08.2022 | Maritim Mobility | In January 2022, Maersk Supply Service, a subsidiary of Danish shipping giant Maersk, is launching S... |
30.08.2022 | Datacenters | With the European data act proposed in February 2022, the Commission aims to make more data availabl... |
30.08.2022 | Green hydrogen will fuel tomorrow’s economy | In a context of dire instability of the oil prices, green hydrogen appears as a beacon of hope for a... |
20.07.2022 | Medical Microinstruments Secures $75M to Advance Robotic Mic... | Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical outcomes fo... |
13.07.2022 | Agomab Raises Additional $40.5 Million Through Series B Exte... | Agomab Therapeutics NV (‘Agomab’) today announced it has extended its Series B financing round with ... |
07.07.2022 | Andera Partners strengthens its Life Sciences team with a ne... | Andera Partners strengthens its organization by welcoming Jan Van den Bossche as a partner within An... |
05.07.2022 | Internship – Infrastructure Investment | About Andera Partners :
Created in 2001, Andera Partners is a major player in private company invest... |
04.07.2022 | Annual CSR Report 2021 / Rapport Annuel RSE 2021 | As an active investor with a 20-year track record of transforming the companies we invest in, Andera... |
13.06.2022 | ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Fina... | ImCheck Therapeutics announced today the close of a EUR 96 million (USD 103 million) financing, co-l... |
08.06.2022 | Andera Partners co-leads $118 Million Oversubscribed Series ... | Andera Partners, a leading European private equity player, announced today that, together with RA Ca... |
17.05.2022 | TRiCares Announces Successful Implantation of Minimally Inva... | Heart valve diseases are among the most serious cardiac conditions, affecting more than 12.7 million... |
13.05.2022 | Andera Partners announces the intermediate closing of its ne... | Andera Partners – a leading private equity player focusing on small- and mid-sized growth companies ... |
11.05.2022 | HR Path receives €225 million in Financing | HR Path today announced a new record round of financing. With this new operation, HR Path intends to... |
03.05.2022 | Andera Partners supports Tubulis in a €60 million Series B f... | Andera Partners, a leading European private equity player, through its biotech and medtech practice ... |
27.04.2022 | Andera Partners to support ElaN Group, the leading technolog... | Andera Partners – a leading player in the field of small cap private equity through its vehicle Ande... |
26.04.2022 | Successful first in human implantation of Topaz Tricuspid He... | - |
07.04.2022 | Andera Partners to sell its Life Sciences’ portfolio company... | Under the agreement, ReViral, a privately held, clinical-stage biopharmaceutical company focused on ... |
01.04.2022 | Andera Partners and Compagnie Lebon launch a co-investment a... | Andera Partners, a leading independent asset management firm operating in private equity, has launch... |
31.03.2022 | Andera Partners announces two promotions to Partner and seve... | MARIANNE HARLÉ has been promoted to Partner in the Andera Croissance team at Andera Partners, which ... |
22.03.2022 | Evommune Initiates Phase 1 Study to Evaluate Safety of EVO10... | Evommune, Inc., a clinical-stage biotechnology company dedicated to the development of transformativ... |
25.02.2022 | Andera Life Sciences is recruiting an Investment Director | Andera Life Sciences team is looking to hire an Investment Director as of March 2022. |
24.02.2022 | Andera Partners creates Andera Partners Transformation A uni... | The independent investment company dedicated to growth SMEs and mid-caps in France and abroad has an... |
22.02.2022 | Andera Partners supports TargED Biopharmaceuticals in €39 mi... | TargED Biopharmaceuticals (“TargED”), a private biotechnology company focused on developing improved... |
17.02.2022 | With nearly €550 million deployed, Andera Partners experienc... | Andera Partners, a leading independent private equity asset management company through its five spec... |
03.02.2022 | Andera Partners invests in green renewable hydrogen producti... | Andera Partners, a leading private equity firm, is investing in Lhyfe – a producer and supplier of g... |
19.01.2022 | JenaValve Announces Strategic Investment and Licensing Agree... | “We are clearly excited about our new partnership with Peijia Medical and the opportunity to bring o... |
13.01.2022 | Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive Licens... | ADVANZ PHARMA Corp. Limited (“ADVANZ PHARMA”), a specialty pharmaceutical company with a strategic f... |
10.01.2022 | BioNTech and Crescendo Biologics announce global collaborati... | BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Crescendo Biologics Ltd (“Crescendo”), a clinical stage i... |
09.12.2021 | Andera Partners announces 1st closing at €84m for Andera Sma... | Andera Partners, a leading private equity player focusing on high-growth SMEs and mid-caps in France... |
22.11.2021 | Vifor Pharma to acquire Sanifit to further strengthen late-s... | Vifor Pharma and Sanifit Therapeutics, a clinical-stage cardio-renal biopharmaceutical company focus... |
15.11.2021 | Andera Partners supports the Founder of ENACO Group in the a... | With more than 200 employees based in the Lille metropolitan area, the Group has trained more than 3... |
28.10.2021 | Agomab Therapeutics to Acquire Origo Biopharma | Agomab Therapeutics NV (‘Agomab’) announced today that it has entered into a definitive agreement un... |
26.10.2021 | Andera Partners supports Exciva in a Series A to fight Alzhe... | Andera Partners – a leading private equity player – through its biotech and medtech activity Andera ... |
29.09.2021 | The role of private equity in the recovery in France and Eur... | CONTENTS |
16.09.2021 | Andera Partners leads Amolyt Pharma’s $80 million Series B a... | Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine an... |
10.09.2021 | Andera Acto supports DP Software Group in its development st... | The fundraising organized by UBS allows its founder and shareholder Patrice Silvère, while retaining... |